Don M. Bailey

Don M. Bailey

Board Member at Lineage Cell Therapeutics, Inc.

Are you Don M. Bailey? Claim your profile
 
  • IDENTIFY executive and board member connections in Don M. Bailey's network.
  • FOLLOW changes in Don M. Bailey's employment.
  • CONNECT with Don M. Bailey through your network of contacts.

Don M. Bailey's Executive Work History


Current
Board Member,
Board Member
Lineage Cell Therapeutics, Inc. DEF 14A on 08/10/2020
Lineage Cell Therapeutics, Inc.
Past
To view Don M. Bailey's complete executive work history,
Education
B.S., Drexel University
M.B.A., Pepperdine University
Age
74
 

Don M. Bailey's Biography


Mr. Bailey previously served as a director and Chairman of Asterias Biotherapeutics, Inc. (AST) from February 2016 until our acquisition of Asterias in March 2019. Mr. Bailey served as President and Chief Executive Officer of Questcor Pharmaceuticals, Inc. (QCOR), a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders, from 2007 until Questcor was acquired by Mallinckrodt plc (MNK) in 2014. He was also a director of Mallinckrodt plc from August 2014 to March 2016, and during this time he was the Chairman of its portfolio committee. He initially joined the Questcor board of directors in 2006 as an independent director and Chairman of its audit committee. From August 2016 to November 2017, Mr. Bailey served as a director of OncoCyte Corporation (OCX). From June 2015 until its acquisition by Acorda Therapeutics, Inc. (ACOR) in May 2016, Mr. Bailey was also an independent director and chairman of the audit committee of Biotie Therapeutics Corp. (BITI), a clinical-stage pharmaceutical company headquartered in Turku, Finland. Mr. Bailey was an independent director and the non-executive chairman of the board of directors of STAAR Surgical Company (STAA), a leader in the development, manufacture, and marketing of minimally invasive ophthalmic products employing proprietary technologies, from 2005 until 2014. Mr. Bailey served on its audit committee and was chair of its nominating and corporate governance committee. Mr. Bailey was the chairman of the board of directors of Comarco, Inc. (CMRO), a defense services company transformed into a wireless communication products company, from 1998 until 2007, where he served as Chief Executive Officer from 1991 until 2000. Mr. Bailey holds a B.S. degree in mechanical engineering from the Drexel Institute of Technology, an M.S. degree in operations research from the University of Southern California and an M.B.A. from Pepperdine University. Mr. Bailey has also served as a board member on several non-profit and academic enterprises. Mr. Bailey is a founding board member of the University of California Irvine's (UCI) Applied Innovation Institute. Mr. Bailey brings to our Board significant knowledge of the pharmaceuticals industry and extensive experience as an executive and board member of publicly traded pharmaceutical companies.

Source: Lineage Cell Therapeutics, Inc. on 08/10/2020

 

By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like Don M. Bailey. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in Don M. Bailey's network.
  • FOLLOW changes in Don M. Bailey's employment.
  • CONNECT with Don M. Bailey through your network of contacts.
 

Access over 250,000 executive and board member profiles.

Example: Don M. Bailey

Don M. Bailey's Connections (96)


Fredrik L. Torstensson
Chief Revenue Officer, Open Systems
David R. Carlucci
Former Chairman, Chief Executive Officer and President, IMS Health
Nicholas Curtis
Chief Executive Officer, LENSAR, Inc.
Dr. Mitchell J. Blutt M.D.
Board Member, Psychiatric Medical Care
Brian M. Culley
Chief Executive Officer, President and Director, Lineage Cell Therapeutics, Inc.
Cavan M. Redmond
Board Member, OncoCyte Corporation
Aditya P. Mohanty
Advisor, Cellect Biotechnology Ltd.
William Annett
Advisor and Former President and Chief Executive Officer, OncoCyte Corporation
Georgia Erbez
Chief Financial Officer, Harpoon Therapeutics, Inc.
Mr. Louis E. Silverman
Chairman and Chief Executive Officer, ADVANCED ICU CARE INC.